Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluviral versus Resfenol for relief of cold or flu symptoms in adults
RBR-3p4npxPhase 3Not yet recruiting
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Mar 2017
- Modality
- Small Molecules, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of influenza A virus A/California/7/2009 X-179A (H1N1) hemagglutinin antigen (formaldehyde inactivated), Resfenol, acetaminophen, chlorpheniramine and phenylephrine in nasopharyngitis and influenza-like illness (ILI) (2 arms), sponsored by Hospital de Clínicas de Porto Alegre. Planned start Mar 2017; status: not yet recruiting.
02
Drugs
influenza A virus A/California/7/2009 X-179A (H1N1) hemagglutinin antigen (formaldehyde inactivated)Resfenolacetaminophenchlorpheniraminephenylephrine
03
Conditions
nasopharyngitisinfluenza-like illness (ILI)
Beyond the preview
Go deeper on RBR-3p4npx.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3p4npx.